Skip to main content

Advertisement

Log in

Streptococcal species as a prognostic factor for mortality in patients with streptococcal bloodstream infections

  • Research
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Streptococcal bloodstream infections (BSIs) are common, yet prognostic factors are poorly investigated. We aimed to investigate the mortality according to streptococcal species and seasonal variation.

Methods

Patients with streptococcal BSIs from 2008 to 2017 in the Capital Region of Denmark were investigated, and data were crosslinked with nationwide registers for the identification of comorbidities. A multivariable logistic regression analysis was performed to assess mortality according to streptococcal species and season of infection.

Results

Among 6095 patients with a streptococcal BSI (mean age 68.1 years), the 30-day mortality was 16.1% and the one-year mortality was 31.5%. With S. pneumoniae as a reference, S. vestibularis was associated with a higher adjusted mortality both within 30 days (odds ratio (OR) 2.89 [95% confidence interval (CI) 1.20–6.95]) and one year (OR 4.09 [95% CI 1.70–9.48]). One-year mortality was also higher in S. thermophilus, S. constellatus, S. parasanguinis, S. salivarius, S. anginosus, and S. mitis/oralis. However, S. mutans was associated with a lower one-year mortality OR 0.44 [95% CI 0.20–0.97], while S. gallolyticus was associated with both a lower 30-day (OR 0.42 [95% CI 0.26–0.67]) and one-year mortality (OR 0.66 [95% CI 0.48–0.93]). Furthermore, with infection in the summer as a reference, patients infected in the winter and autumn had a higher association with 30-day mortality.

Conclusions

The mortality in patients with streptococcal BSI was associated with streptococcal species. Further, patients with streptococcal BSIs infected in the autumn and winter had a higher risk of death within 30 days, compared with patients infected in the summer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All supportive data are available within the article and its supplementary files.

Abbreviations

ATC:

Anatomical therapeutic chemical

BC:

Blood culture

BSI:

Bloodstream infection

CI:

Confidence interval

COPD:

Chronic obstructive pulmonary disease

CVD:

Cerebral vascular disease

DM:

Diabetes mellitus

ICD:

International classification of diseases

IHD:

Ischemic heart disease

MALDI-TOF MS:

Matrix-assisted laser desorption ionization-time of flight mass spectrometry

NOMESCO:

Nordic medico-statistical committee

OR:

Odds ratio

PVD:

Peripheral vascular disease

SD:

Standard deviation

References

  1. Su T-Y, Lee M-H, Huang C-T, Liu T-P, Lu J-J. The clinical impact of patients with bloodstream infection with different groups of Viridans group streptococci by using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). Medicine (Baltimore). 2018;97: e13607.

    Article  CAS  PubMed  Google Scholar 

  2. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J. Predictors of mortality in beta-hemolytic streptococcal bacteremia: A population-based study. J Infect. 2009;58:266–72.

    Article  PubMed  Google Scholar 

  3. Christensen JS, Jensen TG, Kolmos HJ, Pedersen C, Lassen A. Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-day mortality—a hospital-based cohort study. Eur J Clin Microbiol Infect Dis. 2012;31:2719–25.

    Article  CAS  PubMed  Google Scholar 

  4. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med Mass Med Soc. 1996;335:547–54.

    Article  CAS  Google Scholar 

  5. Chamat-Hedemand S, Dahl A, Østergaard L, Arpi M, Fosbøl E, Boel J, et al. Prevalence of infective endocarditis in streptococcal bloodstream infections is dependent on streptococcal species. Circulation. 2020;142:720–30.

    Article  CAS  PubMed  Google Scholar 

  6. Kaul R, McGeer A, Low DE, Green K, Schwartz B, Simor AE. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med. 1997;103:18–24.

    Article  CAS  PubMed  Google Scholar 

  7. Junckerstorff RK, Robinson JO, Murray RJ. Invasive Streptococcus anginosus group infection—does the species predict the outcome? Int J Infect Dis. 2014;18:38–40.

    Article  PubMed  Google Scholar 

  8. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J. Clinical presentations and epidemiology of β-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect. 2009;15:286–8.

    Article  CAS  PubMed  Google Scholar 

  9. Takahashi T, Sunaoshi K, Sunakawa K, Fujishima S, Watanabe H, Ubukata K. Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections. Clin Microbiol Infect. 2010;16:1097–103.

    Article  CAS  PubMed  Google Scholar 

  10. Park JH, Jung J, Kim MJ, Sung H, Kim M-N, Chong YP, et al. Incidence, clinical characteristics, and outcomes of Streptococcus dysgalactiae subspecies equisimilis bacteremia in a tertiary hospital: comparison with S. agalactiae bacteremia. Eur J Clin Microbiol Infect Dis. 2019;38:2253–8.

    Article  CAS  PubMed  Google Scholar 

  11. Cilloniz C, Ewig S, Gabarrus A, Ferrer M, de la Casa JPB, Mensa J, et al. Seasonality of pathogens causing community-acquired pneumonia. Respirology. 2017;22:778–85.

    Article  PubMed  Google Scholar 

  12. Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48:1549–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–9.

    Article  PubMed  Google Scholar 

  14. Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish national patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39:38–41.

    Article  Google Scholar 

  16. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263–8.

    CAS  PubMed  Google Scholar 

  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  18. Corredoira JC, Alonso MP, García JF, Casariego E, Coira A, Rodriguez A, et al. Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis. 2005;24:250–5.

    Article  CAS  PubMed  Google Scholar 

  19. Awada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis. 1992;15:33–48.

    Article  CAS  PubMed  Google Scholar 

  20. Laupland KB, Pasquill K, Parfitt EC, Steele L. Bloodstream infection due to β-hemolytic streptococci: a population-based comparative analysis. Infection. 2019;47:1021–5.

    Article  CAS  PubMed  Google Scholar 

  21. Pierre K, Schlesinger N, Androulakis IP. The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity. Physiol Genomics. 2016;48:719–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by unrestricted research grants from the Research Council and the Department of Cardiology at Herlev-Gentofte University Hospital; the Department of Cardiology at Zealand University Hospital Roskilde; Direktør Jacob Madsen’s og Hustru Olga Madsen’s fond; Helsefonden [Grant number 20-B-0340]; and Skibsreder Per Henriksen, R. og Hustrus Fond. The funders of the study were not involved in the study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit the paper for publication.

Author information

Authors and Affiliations

Authors

Contributions

SCH, AD, and NEB: Design of the project, analysis of data, draft of the manuscript. LØ, MA, EF, JB, KPK, LBO, TKL, GG, CTP: Design of the project, critical revision of data, reviewing and editing the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Sandra Chamat-Hedemand.

Ethics declarations

Conflict of interest

SCH, AD, LØ, MA, EF, JB, KPK, LBO, TKL, GG, CTP and NEB have no conflict of interest.

Ethical approval

The study was performed as a retrospective registry study, where all data were anonymised before use. All data used for this study are held by Statistics Denmark, which also has the administrative rights to the data and encrypts the identification number likewise in all datasets. In retrospective register studies in Denmark, ethics approval and individual consent is not required, and all methods were performed in accordance with the relevant guidelines and regulations. The data handling and storage in the project has been approved by the Danish Data Protection Agency (approval number 2007–58-015/GEH-2014–018 I-Suite number 02736).

Consent for publication

Not applicable.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 102 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chamat-Hedemand, S., Dahl, A., Østergaard, L. et al. Streptococcal species as a prognostic factor for mortality in patients with streptococcal bloodstream infections. Infection 51, 1513–1522 (2023). https://doi.org/10.1007/s15010-023-02025-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-023-02025-8

Keywords

Navigation